## AOS: A.O. Smith Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 1.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($65.43)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is A. O. Smith Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251216T061800 | Somewhat-Bearish | Relevance: 100%
- A. O. Smith Corporation (AOS) has seen its stock decline significantly from its 52-week high and is underperforming the Dow Jones Industrials Average ($DOWI) over multiple timeframes. Despite beating Q3 2025 expectations, shares fell due to a lowered full-year outlook, citing economic weakness in China and a softening North American housing market. Analysts, however, remain moderately optimistic with a "Moderate Buy" rating and a price target suggesting a 14.1% premium to current levels.

**2. Zurn Elkay Water Solutions (ZWS): Valuation Check After Upbeat Q3 Earnings and Fresh Analyst Buy Ratings**
- Source: Simply Wall Street | 20251217T110852 | Neutral | Relevance: 62%
- Analysts have responded positively to Zurn Elkay Water Solutions (ZWS) after strong Q3 earnings and raised guidance, leading to fresh Buy ratings for the stock. Despite a significant share price increase of 27.8% year-to-date and 134.1% over three years, Simply Wall St suggests the company is currently undervalued by 8% with a fair value of $51.25. However, while the narrative supports higher earnings and margin expansion, an earnings-based valuation indicates the stock trades at 42.2 times earnings, higher than the industry average, which could pose a risk if growth slows.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.3%)
- Blackrock Inc.: 6.2% (-1.3%)
- State Street Corpora: 4.8% (-7.4%)
- Impax Asset Manageme: 4.3% (+3.4%)
- Invesco Ltd.: 4.0% (-5.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 28%, ROA 14%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.6B |
| Beta | 1.33 |
| 52W Range | $58.83 - $77.31 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 16.5 |
| Current P/E | 18.0 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.3% to 1.6% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.56% (CS: 59) | Neutral |
| RSI_14 | 56.3 | Neutral |
| MACD Histogram | 0.24 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.002x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $68.19
- **Stop Loss:** $65.43 (4.0% risk)
- **Target:** $70.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 258
- **Position Value:** $17,593.02
- **Portfolio %:** 17.59%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-05 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.91 | $0.94 | +3.6% |
| 2025Q2 | $0.99 | $1.07 | +7.9% |
| 2025Q1 | $0.91 | $0.95 | +4.3% |
| 2024Q4 | $0.89 | $0.85 | -4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*